A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study.
about
Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis.Etanercept for treating axial spondyloarthritis.Anti-TNF discontinuation and tapering strategies in patients with axial spondyloarthritis: a systematic literature review.An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing spondylitis.Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease - a nested case-control study.Dosing down with biologic therapies: a systematic review and clinicians' perspective.Drug levels, immunogenicity and assessment of active sacroiliitis in patients with axial spondyloarthritis under biologic tapering strategy.Association of HLA-B27 with ankylosing spondylitis and clinical features of the HLA-B27-associated ankylosing spondylitis: a meta-analysis.[Tapering and termination of immunosuppressive treatment in spondyloarthritides (including psoriatic arthritis)].Recent advances in ankylosing spondylitis: understanding the disease and management
P2860
Q30239856-B4FA9134-2C01-4C96-A5D7-5171C6D89BFBQ36235821-3A83170B-6D25-4DEB-9826-9D14CA7651D3Q38691419-D666836E-AD23-43DF-881A-403287319174Q38783099-312DFA53-6A8B-4A3E-9B30-495153DF6C01Q38914839-291D356F-5E0D-48BE-820F-375499A04BCBQ38977555-4BFE531C-16DB-4091-B3F7-4BF57AA80AECQ39198863-F76E74EA-92B3-439C-B48C-3A73249CC885Q40056659-F49A883A-A5E3-4C17-B9C8-EE1C7B9A1A3DQ53280274-1E213A22-D9AA-4F2C-BD6E-405623C5E060Q53544912-11E3B18F-BE32-46A1-8C2B-D9C99E402597Q57821877-6A8F196E-24A0-4292-BF96-D949EDE6113D
P2860
A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
A tailored approach to reduce ...... ty score-matched cohort study.
@en
A tailored approach to reduce ...... ty score-matched cohort study.
@nl
type
label
A tailored approach to reduce ...... ty score-matched cohort study.
@en
A tailored approach to reduce ...... ty score-matched cohort study.
@nl
prefLabel
A tailored approach to reduce ...... ty score-matched cohort study.
@en
A tailored approach to reduce ...... ty score-matched cohort study.
@nl
P2860
P50
P1476
A tailored approach to reduce ...... ty score-matched cohort study.
@en
P2093
Katarína Sisol
Michal Uher
P2860
P304
P356
10.1136/ANNRHEUMDIS-2014-205202
P407
P577
2014-08-27T00:00:00Z